Literature DB >> 8567961

Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium.

M L Iruela-Arispe1, P Porter, P Bornstein, E H Sage.   

Abstract

Thrombospondin-1 (TSP1), a multifunctional extracellular matrix glycoprotein, has been shown to suppress the angiogenic response in vivo and in vitro. We hypothesized that TSP1 might play a role in the inhibition of capillary morphogenesis during the endometrial cycle and examined its expression in 46 human endometrial specimens. Our results show that the expression of TSP1 in the endometrium is (a) cycle-dependent, (b) associated with periods of low capillary growth, and (c) regulated by progesterone. TSP1 protein was identified in the basement membrane of capillaries of the functional endometrium during the secretory phase. Abundant expression of TSP1 mRNA in the secretory phase was also detected by in situ hybridization, in contrast to the low levels seen in the proliferative phase. These findings were confirmed by Northern analysis of proliferative and secretory endometrium. Transcripts for TSP1 were observed predominantly in stromal cells, but signal was also detected in some endothelial and smooth muscle cells. Since the proliferation of endometrial tissue is regulated by steroid hormones, we tested the effects of estrogen and progesterone on TSP1 expression by stromal cells isolated from human endometrium. We found that levels of TSP1 mRNA and protein were increased after incubation with progesterone. Maximal stimulation of mRNA was observed after 8 h of treatment with 10-50 microM progesterone, and the effect was suppressed by the progesterone antagonist RU-486. Induction by progesterone was cell-specific and equivalent to the stimulation mediated by PDGF. Finally, the levels of TSP1 present in progesterone-stimulated cultures were sufficient to inhibit the migration of endothelial cells in vitro; this effect was nullified by anti-TSP antibodies. We therefore propose that the production of TSP1 at later stages of the endometrial cycle is linked to the inhibition of vessel formation and that TSP1 expression is progesterone-dependent in this tissue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567961      PMCID: PMC507031          DOI: 10.1172/JCI118429

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Angiogenesis in reproductive tissues.

Authors:  J K Findlay
Journal:  J Endocrinol       Date:  1986-12       Impact factor: 4.286

2.  Thrombospondins.

Authors:  P Bornstein; E H Sage
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

3.  Identification and assay of platelet-derived growth factor-binding proteins.

Authors:  E W Raines; R Ross
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.

Authors:  D E Ingber; J A Madri; J Folkman
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

5.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Thrombospondin in milk, other breast secretions, and breast tissue.

Authors:  J Dawes; P Clezardin; D A Pratt
Journal:  Semin Thromb Hemost       Date:  1987-07       Impact factor: 4.180

8.  A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.

Authors:  R Crum; S Szabo; J Folkman
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

9.  Platelet-associated proteins in human breast cyst fluids.

Authors:  W R Miller; J Dawes
Journal:  Clin Chim Acta       Date:  1985-10-31       Impact factor: 3.786

10.  Collagen synthesis by bovine aortic endothelial cells in culture.

Authors:  H Sage; E Crouch; P Bornstein
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  20 in total

1.  Biomedical application of fuzzy association rules for identifying breast cancer biomarkers.

Authors:  F J Lopez; M Cuadros; C Cano; A Concha; A Blanco
Journal:  Med Biol Eng Comput       Date:  2012-05-24       Impact factor: 2.602

2.  Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction.

Authors:  Walter Cromer; Merilyn H Jennings; Yoshinubo Odaka; J Michael Mathis; J Steven Alexander
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

3.  Effects of detraining on the temporal expression of positive and negative angioregulatory proteins in skeletal muscle of mice.

Authors:  Sara A Olenich; Gerald N Audet; Kathleen A Roberts; I Mark Olfert
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

4.  Deletion of heart-type cytochrome c oxidase subunit 7a1 impairs skeletal muscle angiogenesis and oxidative phosphorylation.

Authors:  Icksoo Lee; Maik Hüttemann; Jenney Liu; Lawrence I Grossman; Moh H Malek
Journal:  J Physiol       Date:  2012-08-06       Impact factor: 5.182

5.  Divergent regulation of angiopoietin-1 and -2, Tie-2, and thrombospondin-1 expression by estrogen in the baboon endometrium.

Authors:  Thomas W Bonagura; Graham W Aberdeen; Jeffery S Babischkin; Robert D Koos; Gerald J Pepe; Eugene D Albrecht
Journal:  Mol Reprod Dev       Date:  2010-05       Impact factor: 2.609

6.  Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1.

Authors:  M D Graubert; M A Ortega; B Kessel; J F Mortola; M L Iruela-Arispe
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

7.  Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.

Authors:  J C Rodriguez-Manzaneque; T F Lane; M A Ortega; R O Hynes; J Lawler; M L Iruela-Arispe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 8.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

9.  Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions.

Authors:  Eva Ruiz; Carmen Alemán; José Alegre; Jasone Monasterio; Rosa Ma Segura; Lluis Armadans; Ana Vázquez; Teresa Soriano; Tomás Fernández de Sevilla
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

10.  Estrogen regulation of thrombospondin-1 in human breast cancer cells.

Authors:  Salman M Hyder; Yayun Liang; Jianbo Wu
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.